@article{3c6f613139834cc8921ee3df4e924428,
title = "Phase II study of sunitinib in tumors with c-KIT mutations: results from the NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocol V",
author = "L. Gien and Z. Song and A. Poklepovic and Collisson, {E. A.} and Mitchell, {E. P.} and Zweibel, {J. A.} and P. Harris and Gray, {R. J.} and V. Wang and McShane, {L. M.} and Rubinstein, {L. V.} and Patton, {D. R.} and Williams, {P. M.} and Hamilton, {S. R.} and Conley, {B. A.} and Arteaga, {C. L.} and Harris, {L. N.} and O'Dwyer, {P. J.} and Chen, {A. P.} and Flaherty, {K. T.}",
note = "Funding Information: This study was coordinated by the ECOG-ACRIN Cancer Research Group (Peter J. O{\textquoteright}Dwyer, MD and Mitchell D. Schnall, MD, PhD, Group Co-Chairs) and supported by the National Cancer Institute of the National Institutes of Health under award numbers: U10CA180820, U10CA180794, UG1CA233302, UG1CA233180, UG1CA233341, and UG1CA189869. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. ",
year = "2022",
month = oct,
doi = "10.1016/S0959-8049(22)01026-7",
language = "English (US)",
volume = "174",
pages = "S86",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
}